PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Accrued Liabilities
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Accrued Liabilities of -$228.01 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$6.44K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$20.12K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$201.45K, a 151.89% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was $374.95K, a 79.21% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$3.30M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$2.37M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$364.16K, a 133.79% decline from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $1.08M, a 93.06% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$6.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$26.57K derived: sum of 2 quarters · filed 2026-05-13 | -$228.01K 10-Q · filed 2026-05-13 | $146.94K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | -$20.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$221.57K 10-Q · filed 2026-02-17 | $153.38K derived: sum of 3 quarters · filed 2026-02-17 | -$990.86K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-09-30 | -$201.45K 10-Q · filed 2025-11-14 | $173.50K derived: sum of 2 quarters · filed 2025-11-14 | -$970.74K derived: sum of 3 quarters · filed 2026-05-13 | -$3.89M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-06-30 | $374.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$769.29K derived: sum of 2 quarters · filed 2026-05-13 | -$3.69M derived: sum of 3 quarters · filed 2026-05-13 | -$3.30M 10-K · filed 2025-09-23 | |
| 2025-03-31 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$4.07M derived: sum of 2 quarters · filed 2026-05-13 | -$3.68M 10-Q · filed 2026-05-13 | -$1.87M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$2.53M 10-Q · filed 2026-02-17 | -$730.70K derived: sum of 3 quarters · filed 2026-02-17 | -$4.01M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | $388.25K 10-Q · filed 2025-11-14 | $2.19M derived: sum of 2 quarters · filed 2025-11-14 | -$1.08M derived: sum of 3 quarters · filed 2025-11-14 | -$2.62M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$1.47M derived: sum of 2 quarters · filed 2025-09-23 | -$3.01M derived: sum of 3 quarters · filed 2025-09-23 | -$2.37M 10-K · filed 2025-09-23 | |
| 2024-03-31 | -$3.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$4.81M derived: sum of 2 quarters · filed 2025-05-14 | -$4.17M 10-Q · filed 2025-05-14 | -$3.20M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$896.81K 10-Q · filed 2025-02-13 | $78.21K derived: sum of 3 quarters · filed 2025-02-13 | -$451.57K derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | $641.21K 10-Q · filed 2024-11-14 | $1.62M derived: sum of 2 quarters · filed 2024-11-14 | $1.09M derived: sum of 3 quarters · filed 2024-11-14 | $1.04M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $975.03K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $445.24K derived: sum of 2 quarters · filed 2024-09-30 | $394.22K derived: sum of 3 quarters · filed 2024-09-30 | -$364.16K 10-K · filed 2024-09-30 | |
| 2023-03-31 | -$529.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$580.81K derived: sum of 2 quarters · filed 2024-05-15 | -$1.34M 10-Q · filed 2024-05-15 | $2.36M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$51.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$809.39K 10-Q · filed 2024-02-14 | $2.89M derived: sum of 3 quarters · filed 2024-02-14 | -$112.38K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$758.38K 10-Q · filed 2023-11-14 | $2.94M derived: sum of 2 quarters · filed 2023-11-14 | -$61.36K derived: sum of 3 quarters · filed 2023-11-14 | $1.13M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $697.02K derived: sum of 2 quarters · filed 2023-09-28 | $1.88M derived: sum of 3 quarters · filed 2023-09-28 | $1.08M 10-K · filed 2023-09-28 | |
| 2022-03-31 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$1.82M derived: sum of 2 quarters · filed 2023-05-15 | -$2.62M 10-Q · filed 2023-05-15 | -$2.06M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $380.82K 10-Q · filed 2023-02-14 | $940.44K derived: sum of 3 quarters · filed 2023-02-14 | $1.34M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | -$806.21K 10-Q · filed 2022-11-14 | -$246.59K derived: sum of 2 quarters · filed 2022-11-14 | $151.60K derived: sum of 3 quarters · filed 2022-11-14 | $1.13M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $559.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $957.82K derived: sum of 2 quarters · filed 2022-09-22 | $1.93M derived: sum of 3 quarters · filed 2022-09-22 | $558.28K 10-K · filed 2022-09-22 | |
| 2021-03-31 | $398.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $1.37M derived: sum of 2 quarters · filed 2022-05-16 | -$1.34K 10-Q · filed 2022-05-16 | $1.24M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $975.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$399.54K 10-Q · filed 2022-02-14 | $842.32K derived: sum of 3 quarters · filed 2022-02-14 | $1.42M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | -$1.38M 10-Q · filed 2021-11-15 | -$133.56K derived: sum of 2 quarters · filed 2021-11-15 | $444.09K derived: sum of 3 quarters · filed 2021-11-15 | -$55.78K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $1.82M derived: sum of 2 quarters · filed 2021-09-28 | $1.32M derived: sum of 3 quarters · filed 2021-09-28 | $50.41K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $577.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $77.78K derived: sum of 2 quarters · filed 2021-05-14 | -$1.19M 10-Q · filed 2021-05-14 | -$982.97K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$499.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | -$1.77M 10-Q · filed 2021-02-16 | -$1.56M derived: sum of 3 quarters · filed 2021-02-16 | -$21.45K derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | -$1.27M 10-Q · filed 2020-11-16 | -$1.06M derived: sum of 2 quarters · filed 2020-11-16 | $478.42K derived: sum of 3 quarters · filed 2020-11-16 | -$440.87K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $208.48K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $1.75M derived: sum of 2 quarters · filed 2020-09-25 | $828.36K derived: sum of 3 quarters · filed 2020-09-25 | $745.67K 10-K · filed 2020-09-25 | |
| 2019-03-31 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $619.88K derived: sum of 2 quarters · filed 2020-05-11 | $537.19K 10-Q · filed 2020-05-11 | -$3.25M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | -$919.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | -$1.00M 10-Q · filed 2020-02-10 | -$4.79M derived: sum of 3 quarters · filed 2020-09-25 | -$4.43M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | -$82.69K 10-Q · filed 2019-11-12 | -$3.87M derived: sum of 2 quarters · filed 2020-09-25 | -$3.51M derived: sum of 3 quarters · filed 2020-09-25 | -$7.36M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | -$3.42M derived: sum of 2 quarters · filed 2020-09-25 | -$7.28M derived: sum of 3 quarters · filed 2020-09-25 | -$8.39M 10-K · filed 2020-09-25 | |
| 2018-03-31 | $367.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$3.49M derived: sum of 2 quarters · filed 2019-05-09 | -$4.60M 10-Q · filed 2019-05-09 | -$2.42M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-12-31 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$4.97M 10-Q · filed 2019-02-11 | -$2.79M derived: sum of 3 quarters · filed 2019-09-12 | -$1.92M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-09-30 | -$1.11M 10-Q · filed 2018-11-09 | $1.07M derived: sum of 2 quarters · filed 2019-09-12 | $1.94M derived: sum of 3 quarters · filed 2019-09-12 | -$3.50M derived: sum of 4 quarters · filed 2019-09-12 | |
| 2017-06-30 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $3.05M derived: sum of 2 quarters · filed 2019-09-12 | -$2.39M derived: sum of 3 quarters · filed 2019-09-12 | $2.73M 10-K · filed 2019-09-12 | |
| 2017-03-31 | $867.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$4.57M derived: sum of 2 quarters · filed 2018-05-14 | $546.47K 10-Q · filed 2018-05-14 | $512.27K derived: sum of 4 quarters · filed 2018-09-13 | |
| 2016-12-31 | -$5.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$320.91K 10-Q · filed 2018-02-12 | -$355.12K derived: sum of 3 quarters · filed 2018-09-13 | $1.80M derived: sum of 4 quarters · filed 2018-09-13 | |
| 2016-09-30 | $5.12M 10-Q · filed 2017-11-13 | $5.08M derived: sum of 2 quarters · filed 2018-09-13 | $7.24M derived: sum of 3 quarters · filed 2018-09-13 | $6.64M derived: sum of 4 quarters · filed 2018-09-13 | |
| 2016-06-30 | -$34.21K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13 | $2.12M derived: sum of 2 quarters · filed 2018-09-13 | $1.52M derived: sum of 3 quarters · filed 2018-09-13 | $1.68M 10-K · filed 2018-09-13 | |
| 2016-03-31 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $1.55M derived: sum of 2 quarters · filed 2017-05-15 | $1.71M 10-Q · filed 2017-05-15 | $4.96M derived: sum of 4 quarters · filed 2017-09-25 | |
| 2015-12-31 | -$601.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$445.11K 10-Q · filed 2017-02-10 | $2.81M derived: sum of 3 quarters · filed 2017-09-25 | $2.81M derived: sum of 4 quarters · filed 2017-09-25 | |
| 2015-09-30 | $156.06K 10-Q · filed 2016-11-14 | $3.41M derived: sum of 2 quarters · filed 2017-09-25 | $3.41M derived: sum of 3 quarters · filed 2017-09-25 | $4.39M derived: sum of 4 quarters · filed 2017-09-25 | |
| 2015-06-30 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $3.25M derived: sum of 2 quarters · filed 2017-09-25 | $4.24M derived: sum of 3 quarters · filed 2017-09-25 | $4.67M 10-K · filed 2017-09-25 | |
| 2015-03-31 | $1.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | $986.74K derived: sum of 2 quarters · filed 2016-05-16 | $1.41M 10-Q · filed 2016-05-16 | $884.75K derived: sum of 4 quarters · filed 2016-09-19 | |
| 2014-12-31 | $985.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $1.41M 10-Q · filed 2016-02-12 | $883.37K derived: sum of 3 quarters · filed 2016-09-19 | $644.44K derived: sum of 4 quarters · filed 2016-09-19 | |
| 2014-09-30 | $427.33K 10-Q · filed 2015-11-12 | -$102.00K derived: sum of 2 quarters · filed 2016-09-19 | -$340.92K derived: sum of 3 quarters · filed 2016-09-19 | -$364.92K derived: sum of 4 quarters · filed 2016-09-19 | |
| 2014-06-30 | -$529.33K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-19 | -$768.26K derived: sum of 2 quarters · filed 2016-09-19 | -$792.25K derived: sum of 3 quarters · filed 2016-09-19 | -$311.86K 10-K · filed 2016-09-19 | |
| 2014-03-31 | -$238.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-12 | -$262.92K derived: sum of 2 quarters · filed 2015-05-12 | $217.47K 10-Q · filed 2015-05-12 | -$76.34K derived: sum of 4 quarters · filed 2015-09-18 | |
| 2013-12-31 | -$23.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | $456.40K 10-Q · filed 2015-02-12 | $162.58K derived: sum of 3 quarters · filed 2015-09-18 | $597.79K derived: sum of 4 quarters · filed 2015-09-18 | |
| 2013-09-30 | $480.39K 10-Q · filed 2014-11-14 | $480.39K 10-Q · filed 2013-11-13 | $186.57K derived: sum of 2 quarters · filed 2015-09-18 | $621.78K derived: sum of 3 quarters · filed 2015-09-18 | $868.99K derived: sum of 4 quarters · filed 2015-09-18 |
| 2013-06-30 | -$293.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18 | $141.39K derived: sum of 2 quarters · filed 2015-09-18 | $388.60K derived: sum of 3 quarters · filed 2015-09-18 | -$1.48M 10-K · filed 2015-09-18 | |
| 2013-03-31 | $435.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $682.42K derived: sum of 2 quarters · filed 2014-05-12 | -$1.18M 10-Q · filed 2014-05-12 | -$908.10K derived: sum of 4 quarters · filed 2014-09-12 | |
| 2012-12-31 | $247.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$1.62M 10-Q · filed 2014-02-14 | -$1.34M derived: sum of 3 quarters · filed 2014-09-12 | -$90.03K derived: sum of 4 quarters · filed 2014-09-12 | |
| 2012-09-30 | -$1.86M 10-Q · filed 2013-11-13 | -$1.59M derived: sum of 2 quarters · filed 2014-09-12 | -$337.24K derived: sum of 3 quarters · filed 2014-09-12 | -$23.97K derived: sum of 4 quarters · filed 2014-09-12 | |
| 2012-06-30 | $273.41K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-12 | $1.53M derived: sum of 2 quarters · filed 2014-09-12 | $1.84M derived: sum of 3 quarters · filed 2014-09-12 | $851.55K 10-K · filed 2014-09-12 | |
| 2012-03-31 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-13 | $1.57M derived: sum of 2 quarters · filed 2013-05-13 | $578.14K 10-Q · filed 2013-05-13 | $1.26M derived: sum of 4 quarters · filed 2013-09-27 | |
| 2011-12-31 | $313.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | -$675.13K 10-Q · filed 2013-02-13 | $6.80K derived: sum of 3 quarters · filed 2013-09-27 | -$94.36K derived: sum of 4 quarters · filed 2013-09-27 | |
| 2011-09-30 | -$988.40K 10-Q · filed 2012-11-14 | -$306.46K derived: sum of 2 quarters · filed 2013-09-27 | -$407.63K derived: sum of 3 quarters · filed 2013-09-27 | -$1.42M derived: sum of 4 quarters · filed 2013-09-27 | |
| 2011-06-30 | $681.93K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | $580.77K derived: sum of 2 quarters · filed 2013-09-27 | -$433.88K derived: sum of 3 quarters · filed 2013-09-27 | -$519.90K 10-K · filed 2013-09-27 | |
| 2011-03-31 | -$101.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | -$1.12M derived: sum of 2 quarters · filed 2012-05-14 | -$1.20M 10-Q · filed 2012-05-14 | ||
| 2010-12-31 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$1.10M 10-Q · filed 2012-02-14 | |||
| 2010-09-30 | -$86.02K 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $278.09K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |